PNC Financial Services Group
STRO icon

PNC Financial Services Group’s Sutro Biopharma STRO Stock Holding History

PNC Financial Services Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54K Hold
62
– – ﹤0.01% 4659
2025
Q4 		$717 Buy
62
+1
+2% +$9 ﹤0.01% 4766
2025
Q3 		$533 Sell
61
-16
-21% -$136 ﹤0.01% 4794
2025
Q2 		$549 Buy
77
+10
+15% +$82 ﹤0.01% 4671
2025
Q1 		$434 Buy
67
+62
+1,240% +$976 ﹤0.01% 4668
2024
Q4 		$94 Hold
5
– – ﹤0.01% 4711
2024
Q3 		$176 Hold
5
– – ﹤0.01% 4690
2024
Q2 		$149 Buy
+5
New +$198 ﹤0.01% 4699

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PNC Financial Services Group's STRO Position: Q1 2026 in Review

PNC Financial Services Group held its Sutro Biopharma (STRO) position steady in Q1 2026 at 62 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4659.

PNC Financial Services Group first reported a position in STRO in Q2 2024 and has held it in 8 quarters since. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • PNC Financial Services Group held 62 shares of Sutro Biopharma worth $1.54K as of Q1 2026.
  • PNC Financial Services Group left its Sutro Biopharma share count unchanged in Q1 2026.
  • Sutro Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4659 holding.
  • PNC Financial Services Group first reported a position in Sutro Biopharma in Q2 2024 and has held it in 8 quarters since.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.